GSK3B and intrahepatic cholangiocarcinoma: These results suggested that activation of PI3K/AKT signaling pathway and downstream molecules, such as GSK3β and CyclinD1, by PTP4A1 in ICC cells may be the underlying mechanism for its proliferation-promoting effect.